Groundbreaking VE303 Therapeutic Candidate for Clostridium Difficile Infection (CDI) Sparks Transformation in Pharma Landscape: Detailed Analysis Reveals Potential Market Impact Though 2032
January 29, 2024 12:57 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "VE303 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Cutting-Edge VE303 Drug Expected...
Market Overview of Centrexion Therapeutics' CNTX-4975 Drug, 2023-2032, Potentially Revolutionizing the Treatment Landscape for Osteoarthritis
January 29, 2024 12:41 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "CNTX-4975 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. Emerging therapeutic...
Overview of Sorrento Therapeutics' RTX (MCP-101, resiniferatoxin) Drug Across the 7MM, 2023-2032
January 29, 2024 12:37 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "RTX Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This reports delivers an...
TTP399 Drug Insights and Forecasts Across the 7MM, 2023-2032
January 29, 2024 12:31 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TTP399 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The research outlined in this...
XP-3924 Report 2023: Drug Development, Sales, and Market Forecast to 2032
January 29, 2024 12:20 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "XP-3924 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
Emerging IMCY-0098 Drug Insights and Market Forecasts to 2032: Type 1 Diabetes Mellitus Market Set for Expansion
January 29, 2024 12:19 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "IMCY-0098 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This market forecast of the...
Emerging ONC201 Drug Set to Transform Glioblastoma Multiforme Treatment Landscape: Drug Insights and Market Forecasts to 2032
January 29, 2024 12:18 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "ONC201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
PF-06425090 (C. difficile Vaccine): Pharmaceutical Development and Market Forecast Insights to 2032
January 29, 2024 12:17 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PF-06425090 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report casts light...
Paroxysmal Nocturnal Hemoglobinuria Treatment Advances with Comprehensive Danicopan Market Forecast to 2032
January 24, 2024 10:44 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Danicopan Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
Glofitamab (CD20-TCB, RG6026) for Diffuse Large B-cell lLymphoma (DLBCL) - Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 09:23 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Glofitamab Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...